Studies with heterologous antilymphocytic serum as a therapy for chronic lymphocytic leukemia.
D000961:Antilymphocyte Serum / Q000008:administration & dosage* / Q000009:adverse effects; D001787:Blood Group Incompatibility; D002859:Chromium Isotopes; D006386:Hemagglutination Tests; D006505:Hepatitis / Q000209:etiology; D006801:Humans; D007945:Leukemia, Lymphoid / Q000276:immunology / Q000628:therapy*; D007951:Leukemia, Myeloid / Q000276:immunology; D007958:Leukocyte Count; D007962:Leukocytes / Q000276:immunology; D008231:Lymphopenia / Q000276:immunology; D014581:Urticaria / Q000209:etiology
D000961:Antilymphocyte Serum; D002859:Chromium Isotopes